# The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)

> **NCT05983536** · — · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 1200 (estimated)

## Conditions studied

- HIV Seropositivity
- Cancer
- Blood Disease

## Interventions

- **DIAGNOSTIC_TEST:** HIV Ag +Ab Assay Kit (Sysmex)

## Key facts

- **NCT ID:** NCT05983536
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-20
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05983536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05983536, "The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05983536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*